The store will not work correctly when cookies are disabled.
3-[3-(4-Fluorophenyl)-1H-Indazol-5-yl]-1H-1,2,4-Triazole
ID: ALA3984777
PubChem CID: 10149380
Max Phase: Preclinical
Molecular Formula: C15H10FN5
Molecular Weight: 279.28
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Fc1ccc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)cc1
Standard InChI: InChI=1S/C15H10FN5/c16-11-4-1-9(2-5-11)14-12-7-10(15-17-8-18-21-15)3-6-13(12)19-20-14/h1-8H,(H,19,20)(H,17,18,21)
Standard InChI Key: ABLPXBMVAAHVFU-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
21.5510 -13.2401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5498 -14.0596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2579 -14.4686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2561 -12.8313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9647 -13.2365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9695 -14.0551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7495 -14.3036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2269 -13.6384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.7418 -12.9791 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.0053 -15.0747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4603 -15.6851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7167 -16.4602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5178 -16.6261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0619 -16.0107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8026 -15.2380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7759 -17.4014 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.8418 -14.4677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0982 -14.1380 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5509 -14.7449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9590 -15.4530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7584 -15.2836 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
7 10 1 0
13 16 1 0
2 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 17 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 279.28 | Molecular Weight (Monoisotopic): 279.0920 | AlogP: 3.15 | #Rotatable Bonds: 2 |
Polar Surface Area: 70.25 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.93 | CX Basic pKa: 2.55 | CX LogP: 2.42 | CX LogD: 2.42 |
Aromatic Rings: 4 | Heavy Atoms: 21 | QED Weighted: 0.59 | Np Likeness Score: -1.51 |
References
1. (2002) Indazole derivatives as JNK inhibitors and compositions and methods related thereto, |